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Abstract
Background: Previous studies have reported on adverse neonatal outcomes associated with parity and maternal
age. Many of these studies have relied on cross-sectional data, from which drawing causal inference is complex.
We explore the associations between parity/maternal age and adverse neonatal outcomes using data from cohort
studies conducted in low- and middle-income countries (LMIC).
Methods: Data from 14 cohort studies were included. Parity (nulliparous, parity 1-2, parity ≥3) and maternal age
(<18 years, 18-<35 years, ≥35 years) categories were matched with each other to create exposure categories, with those
who are parity 1-2 and age 18-<35 years as the reference. Outcomes included small-for-gestational-age (SGA), preterm,
neonatal and infant mortality. Adjusted odds ratios (aOR) were calculated per study and meta-analyzed.
Results: Nulliparous, age <18 year women, compared with women who were parity 1-2 and age 18-<35 years had
the highest odds of SGA (pooled adjusted OR: 1.80), preterm (pooled aOR: 1.52), neonatal mortality (pooled aOR:
2.07), and infant mortality (pooled aOR: 1.49). Increased odds were also noted for SGA and neonatal mortality for
nulliparous/age 18-<35 years, preterm, neonatal, and infant mortality for parity ≥3/age 18-<35 years, and preterm
and neonatal mortality for parity ≥3/≥35 years.
Conclusions: Nulliparous women <18 years of age have the highest odds of adverse neonatal outcomes. Family
planning has traditionally been the least successful in addressing young age as a risk factor; a renewed focus must
be placed on finding effective interventions that delay age at first birth. Higher odds of adverse outcomes are also
seen among parity ≥3 / age ≥35 mothers, suggesting that reproductive health interventions need to address the
entirety of a woman’s reproductive period.
Funding: Funding was provided by the Bill & Melinda Gates Foundation (810-2054) by a grant to the US Fund for
UNICEF to support the activities of the Child Health Epidemiology Reference Group.
Introduction
Parity and maternal age have been shown to increase the
risk of adverse neonatal outcomes, such as intrauterine
growth restriction (IUGR), prematurity, and mortality
[1-5]. Nulliparity may confer risk through complications
during childbirth such as obstructed labor [6], whereas
high parity has been linked to increased risk of hyperten-
sion, placenta previa, and uterine rupture [4]. Several
studies have hypothesized that in young mothers, mater-
nal-fetal competition for nutrients and/or the mother’s
incomplete physical growth might contribute to adverse
neonatal outcomes [7]. Older women experience an
increase in the incidence of congenital abnormalities as
well as maternal morbidities such as hypertension and
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gestational diabetes [8,9]. However, some literature has
suggested that controlling for socioeconomic status heav-
ily attenuates or eliminates associations of adolescence
and of high parity with adverse outcomes [10,11].
Despite the abundance of existing literature on parity
and maternal age as risk factors for adverse neonatal
outcomes, methodological issues in many studies make
it difficult to draw strong conclusions. Several studies
have utilized cross-sectional data, often Demographic and
Health Surveys (DHS) [12-14]. Cross-sectional studies
cannot assess causality easily. Furthermore, information
recorded at the time of interview, i.e. confounders like
socioeconomic factors, may fail to reflect the true condi-
tion at the time of pregnancy and delivery. In addition, the
quality of relevant variables may be poor in surveys. For
example, gestational age data dependent on maternal
recall are expected to be less accurate than data from pro-
spective cohort studies where women of reproductive age
are closely tracked and/or estimated gestational age is cor-
roborated through clinical assessment.
Studies have also failed to examine the potential con-
founding effects of other reproductive health-related
variables, socioeconomic status, or maternal nutrition.
One systematic review found an association between
nulliparity and SGA, but not prematurity; however, it
failed to limit the studies included in the meta-analysis
to those that controlled for maternal age [4]. Further-
more, the studies that do control for these confounders
often fail to indicate whether the adjustment may have
altered the associations [3], preventing us from under-
standing the biological or confounding mechanisms
linking parity and maternal age to poor outcomes.
Categorizations and definitions of risk factors and out-
comes described in the present literature have differed
across studies. For example, the low-risk reference cate-
gory for parity varies substantially across studies (i.e.
birth orders 2-3 [4], 2-4 [15], and 2-5 [16]). Definitions
of young age also differ, with cut-offs ranging from 16
to 18 [2], and some authors have evaluated age since
first menarche. Definitions of outcomes also vary. Var-
ious proxies for IUGR have been used [17,18], the most
common being small-for-gestational-age (SGA) defined
as birthweight below the 10th percentile of a gender-spe-
cific reference distribution of birthweight at a particular
gestational age. Such variety in exposure and outcome
definitions makes it difficult to compare results across
studies.
An objective of the family planning section of this
supplement is to derive the best estimate of associations
between reproductive health-related maternal risk fac-
tors and adverse neonatal outcomes to include in the
Lives Saved Tool (LiST). LiST is a software product that
produces evidence-based estimates of changes in mater-
nal and child mortality if a health intervention is scaled
up in a particular country [19]. We used original data
from prospective cohort studies to examine parity and
maternal age as exposures for adverse neonatal and
infant outcomes. Our aim was to apply standardized
categorizations and definitions for the exposure and out-
come variables across studies in order to obtain best
estimates. We controlled for available confounders such
as socioeconomic status and maternal nutrition to
examine their effect on associations. The findings will
help us understand if and how family planning programs
may impact neonatal and infant survival, as well as bet-
ter evaluate the potential mechanisms linking these risk
factors to adverse outcomes.
Methods
Our general approach was to identify individual pro-
spective birth cohorts for which we conducted a stan-
dardized set of analyses, and then to meta-analyze the
individual study associations. First, population-based,
prospective cohort studies from LMIC with information
on parity and maternal age, newborn birthweight (col-
lected within the first 72 hours), and gestational age
were identified from studies extracted for a separate
analysis [Table 1]. Briefly, the separate analysis sought
to estimate neonatal and infant mortality risk of SGA
and preterm births. Datasets were identified through a
literature review conducted in September 2009. We
searched Medline and WHO regional databases to identify
birth cohorts that contained relevant data including gesta-
tional age, birthweight, and vital status on newborns up to
at least one month of life. Investigators of those studies
were contacted and invited to contribute data or conduct
analysis using a standardized analysis plan. Additional
birth cohorts from ongoing or recently completed mater-
nal-health studies were identified by word-of-mouth by
members of the Child Health Epidemiology Reference
Group (CHERG) SGA-Preterm Birth working group.
More details are available in a separate publication [20].
Fourteen datasets were identified [21-35].
Independent variable
For each dataset, nine risk categories were created,
matching the three parity categories (nulliparity, parity 1-
2 as reference parity, parity ≥3) and three maternal age
categories (<18 years, 18-<35 years as reference age, ≥35
years) [Table 2]. These categories were chosen because
DHS uses these cut-offs to identify “high-risk fertility
behavior” [36,37]. We defined parity as the number of
live births before the current pregnancy. The nine risk
categories are mutually exclusive. Throughout the paper,
we will use the denotation of “parity category/age cate-
gory” (i.e. nulliparous / age <18) to indicate categories of
women who belong to both the indicated parity category
and age category.
Kozuki et al. BMC Public Health 2013, 13(Suppl 3):S2
http://www.biomedcentral.com/1471-2458/13/S3/S2
Page 2 of 10
Women in a risk category were compared to those in
the reference category (parity 1-2/age 18-<35), creating
a binary exposure variable for each risk category. The
prevalence in each risk category was calculated sepa-
rately by study. We only conducted analyses on a risk
category if at least half of the studies (seven out of 14)
reported having a prevalence of 5% or more in that
category. Calculating associations for risk categories
with extremely low prevalence would produce unstable
estimates with wide uncertainty.
Outcome variables
A common SGA reference distribution and preterm
definition were used across all studies. We defined SGA
Table 1 Description of studies included in the analysis
Country N Type of study Setting Facility
delivery
rate
%
LBW
Method of gestational age
measurement
Asia India (2000)
[25]
12,936 RCT of newborn Vitamin A
supplementation
Rural 63 33 LMP
Nepal (1999)
[26]
4,130 Cluster RCT of multiple micronutrient
supplementation
Rural 6 39 LMP
Nepal (2003)
[28]
1,106 RCT of antenatal micronutrient
supplementation
Peri-
urban
53 22 Ultrasound
Nepal (2004)
[27]
23,662 Cluster RCT of newborn skin-umbilical
cord cleansing with chlorhexidine
Rural 10 30 LMP
Philippines
(1983)[29]
3,080 Longitudinal Health-nutritional survey of
infant feeding patterns
Urban 34 11 LMP, Ballard
Thai (2001)
[30]
4,245 Prospective follow-up of birth cohort Urban 99 8 Best obstetric estimate (LMP,
ultrasound or neonatal assessment)
Africa Burkina Faso
(2004)[31]
1,373 RCT of multiple micronutrient
supplementation
Rural 77 17 Ultrasound at recruitment
Burkina Faso
(2006)[34]
1,316 RCT of maternal fortified food
supplementation
Rural 84 16 Ultrasound at recruitment
Tanzania
(2001)[32]
7,752 RCT of maternal multiple micronutrient
supplementation
Urban 98 10 LMP
Zimbabwe
(1997)[33,35]
14,110 RCT of postpartum maternal and neonatal
Vitamin A supplementation
Urban 88 14 Capurro
Americas Brazil (1982)
[21]
5,914 Prospective cohort study Urban 100 7 LMP
Brazil (1993)
[22]
5,279 Prospective cohort study Urban 100 9 LMP, Dubowitz
Brazil (2004)
[23]
4,287 Prospective cohort study Urban 100 11 LMP, Dubowitz, ultrasound if available
Peru (1995)
[24]
978 RCT of maternal zinc supplementation Urban 100 4 LMP, clinical indications
RCT = randomized controlled trial
LMP = last menstrual period
LBW = low birthweight
Table 2 Parity/age categories and their median and range of prevalence across included cohort studies
Nulliparous Parity 1-2 (reference) Parity ≥3
Age <18 Median: 7.37%
Range: 0.13-12.74%
N*=9
Median: 0.76%
Range: 0.01-2.65%
N=0
Median: 0.00
Range: 0.00-0.22%
N=0
Age 18-<35
(reference)
Median: 28.27%
Range: 1.20-43.72%
N=14
Median: 39.93%
Range: 33.28-51.50%
N=14
Median: 13.42%
Range: 7.17-35.64%
N=14
Age ≥35 Median: 0.08%
Range: 0.00-1.54%
N=0
Median: 0.71%
Range: 0.00-6.30%
N=2
Median: 5.52%
Range: 0.17-9.19%
N=7
Median and Range are described across all 14 cohort studies.
*The Ns indicated reflects how many studies out of the 14 included studies have ≥5% prevalence in that category.
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as below the 10th percentile of the U.S. 1991 reference
distribution described by Alexander and colleagues [38].
We used this reference distribution, as this is the most
commonly used and cited, allowing for comparability
with other studies. Preterm was defined as below 37
completed weeks of gestation. The method of gestational
age measurement for each study is listed in Table 1.
We also created the composite outcome variables term-
appropriate for-gestational-age (AGA), term-SGA,
preterm-AGA, and preterm-SGA, with term-AGA as the
reference. When mortality information was available,
neonatal mortality was defined as death within 28 days,
and infant mortality as death within 365 days. All new-
borns were included in the analysis examining the out-
comes of preterm, neonatal, and infant mortality, even if
the child did not have a weight available to examine SGA
as an outcome.
Data analysis
Datasets were first analyzed individually. Ten of the 14
cohort study datasets were available to the primary
author to analyze; the remaining four datasets were ana-
lyzed by collaborators using a standardized template.
Logistic regression was used to calculate the odds ratio
between a risk category (inclusion criteria for risk cate-
gory described in “independent variables” section) and
an adverse neonatal outcome, with parity 1-2/age 18-
<35 women as reference. In addition to unadjusted ana-
lysis, available socioeconomic and maternal nutritional
variables were placed in the model to determine if they
confounded the association [See Supplemental Table 1
in Additional file 1 for the list of covariates adjusted for
during analyses]. Odds ratios, instead of relative risks,
were used, due to convergence issues in adjusted analy-
sis. The datasets were not pooled, as each dataset con-
tained a different set of possible confounders. Not all
studies reported an association for each exposure and
outcome due to low prevalence in their respective stu-
dies. Once the associations were calculated at the study
level, they were meta-analyzed using the metan com-
mand in Stata. Random effects models were used to
address heterogeneity across studies.
We also conducted sensitivity analyses to explore the
risk of more extreme cut-offs of parity and maternal age
than what DHS presently defines as high risk, using
the ten datasets available to the primary author. We
examined the impact of higher parity and younger age by
comparing the following adjusted odds ratios (aOR): 1)
higher parity: parity ≥5/age 18-<35 versus parity ≥3/age
18-<35, 2) higher parity among high age women: parity
≥5/age ≥35 versus parity ≥3/age ≥35, and 3) younger age
among nulliparous women: nulliparous/age <16 versus
nulliparous/age <18. For all of these aORs, the reference
group remained parity 1-2/age 18-<35. No analysis was
conducted to examine parity 1-2/age <16 because of the
small sample size across all studies in this exposure
category.
We considered an alpha value of 0.05 to be statistically
significant and all tests were two-sided. We used Stata
12.0 (StataCorp. 2009. College Station, TX: StataCorp LP)
for analysis.
Results
Distribution of parity-age exposure in study populations
Table 2 presents the median and range of prevalence for
each parity/age risk category across all 14 studies. The
reference parity 1-2/age 18-<35 category had a median
prevalence of 39.9% (range: 33.3-51.5%). Four other
categories had at least seven of the 14 studies with pre-
valence over 5% in the respective categories. All 14 stu-
dies reported a prevalence of over 5% for nulliparous/
age 18-<35 and parity ≥3/age 18-<35, with median pre-
valence of 28.3% and 13.4% respectively. The nullipar-
ous/age <18 and parity ≥3/age ≥35 categories both had
at least seven studies reporting over 5% prevalence. The
analyses were only conducted for these four risk
categories.
Prevalence of adverse neonatal outcomes in study
populations
The prevalence of adverse neonatal outcomes in each
study is shown in Supplemental Table 2 in Additional
file 1. SGA prevalence was generally lowest in Latin
America (range: 10.8-21.1%) and highest in Asia, parti-
cularly South Asia (South Asia range: 52.3-61.5%).
Preterm prevalence followed a similar regional pattern.
Neonatal mortality rates were highest in South Asia
(highest rate: 42 per 1000 live births in Nepal), but
infant mortality rates were comparable for the South
Asian and African studies, with Latin America having
the lowest rates of neonatal and infant mortality.
Associations between parity-age exposure categories
and outcomes
In nearly all cases for SGA, preterm, and mortality out-
comes, inclusion of socioeconomic and maternal nutri-
tion variables did not alter the effect sizes by more than
10% (unadjusted ORs not presented). In cases where the
effect size differed by more than 10%, the 95% confi-
dence intervals (CI) overlapped.
We report the meta-analyzed associations below. The
reference parity/age category is parity 1-2/age 18-<35
for all analyses.
SGA
Nulliparous/age <18 had a statistically significant
adverse association with SGA (see Table 3). Both nulli-
parous/age <18 (aOR: 1.80, 95% CI: 1.62-2.01) and
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nulliparous/age 18-<35 (aOR 1.51, 95% CI: 1.39-1.64)
had increased risk of SGA. The confidence interval for
these two associations overlapped slightly. The parity
≥3/age 18-<35 category did not have an adverse associa-
tion. Instead, we saw a small but statistically significant
protective effect against SGA (aOR: 0.92, 95% CI 0.86-
0.99). The parity ≥3/age ≥35 category had no significant
association.
Preterm
Almost all exposure categories had statistically significant
associations with preterm birth. The nulliparous/age <18
category had the highest risk of preterm birth (aOR: 1.52,
95% CI 1.40-1.66), followed by parity ≥3/age ≥35 (aOR
1.43, 95% CI: 1.21-1.69) and parity ≥3/age 18-<35 (aOR:
1.20, 95% CI: 1.06-1.35) (see Table 3).
Gestational age-SGA combined categories
Term-SGA. Nulliparous/age <18 mothers had a signifi-
cant association with term-SGA (aOR: 1.81, 95% CI:
1.51-2.16). Nulliparous/age 18-<35 had slightly weaker
but significant associations. The parity ≥3/age 18-<35
women had a significant protective association (aOR:
0.88, 95% CI: 0.81-0.96), and parity ≥3/age ≥35 had no
association. Preterm-AGA. Nulliparous/age <18 had the
largest association (aOR: 1.83, 95% CI: 1.48-2.27). Nulli-
parous/age 18-<35 and parity ≥3/age ≥35 had 30-40%
significant increase in odds, and parity ≥3/age 18-<35
had no significant association. Preterm-SGA. Nullipar-
ous/age <18 mothers once again had the highest asso-
ciation (aOR: 3.14, 95% CI: 2.18-4.53), followed by
nulliparous/age 18-<35 (aOR: 2.67, 95% CI: 1.97-3.61).
Parity ≥3/age ≥35 had slightly increased odds (aOR:
1.24, 95% CI: 1.06-1.44), and parity ≥3/age 18-<35 had
no association. (See Table 3 and Figure 1). Relative risks
(RR) were requested for use in LiST, and the unadjusted
RRs can be found in Supplemental Table 3 in Additional
file 1.
Neonatal and infant mortality
All datasets contributed systematic neonatal mortality
data except Peru (very low incidence). All risk categories
had statistically significant increased odds of neonatal
mortality, but the magnitude of the effect size varied.
Nulliparous/age <18 had an approximately two-fold
increased risk (aOR: 2.07, 95% CI 1.69-2.54). Nullipar-
ous/age 18-<35 had a 28% increase in odds (95% CI,
1.07-1.51), parity ≥3/age 18-<35 had a 30% increase in
odds (95% CI: 1.11-1.51), and parity ≥3/age ≥35 had a
66% increase in odds (95% CI: 1.23-2.23). We had fewer
studies contributing infant mortality, as five of the data-
sets did not follow children systematically up to one
year. For infant mortality, the statistically significant
association only remained for nulliparous/age <18 (aOR
1.49, 95% CI 1.13-1.97) and parity ≥3/age 18-<35 (aOR
1.40, 95% CI 1.04-1.89) (See Table 3).
Examining higher parity and lower age cut-offs
Higher parity and lower age cut-offs were examined for
the ten datasets available to the primary author. When
increasing the parity cut-off to 5, we did not notice
large differences in odds ratios. For both parity ≥5/age
18-<35 and parity ≥5/age ≥35, the magnitude of all the
associations were very similar to parity cut-off of 3. For
nulliparous/age <16, we saw a consistent increase in
odds ratios compared to nulliparous/age <18, particu-
larly for preterm outcomes. However, none of the asso-
ciations were statistically significantly different between
the two exposure categories (Supplemental Table 4a-c
in Additional file 1).
Discussion
Our analyses found associations with adverse neonatal
outcomes for some reproductive characteristics pre-
viously considered high risk, while not for others. Nulli-
parous women had significant associations with adverse
outcomes, but particularly when mothers were also of
Table 3 Adjusted odds ratios for adverse outcomes, by reproductive health risk factor categories
Nulliparous / Age <18 Nulliparous / Age 18-<35 Parity ≥3 / Age 18-<35 Parity ≥3 / Age ≥35
Outcome N* aOR 95% CI N* aOR 95% CI N* aOR 95% CI N* aOR 95% CI
SGA (reference: AGA) 14 1.80 1.62, 2.01 14 1.51 1.39, 1.64 14 0.92 0.86, 0.99 13 0.98 0.87, 1.09
Preterm (reference: term) 14 1.52 1.40, 1.66 14 1.09 0.99, 1.21 14 1.20 1.06, 1.35 12 1.43 1.21, 1.69
Term-SGA (reference: term-AGA) 14 1.81 1.51, 2.16 14 1.64 1.46, 1.85 14 0.88 0.81, 0.96 13 1.06 0.93, 1.20
Preterm-AGA (reference: term-AGA) 13 1.75 1.56, 1.98 13 1.30 1.09, 1.54 13 1.13 0.98, 1.30 12 1.39 1.16, 1.65
Preterm-SGA (reference: term-AGA) 11 3.14 2.18, 4.53 14 2.67 1.97, 3.61 13 1.07 0.83, 1.38 12 1.24 1.06, 1.44
Neonatal Mortality 12 2.07 1.69, 2.54 13 1.28 1.07, 1.51 12 1.30 1.11, 1.51 10 1.66 1.23, 2.23
Infant Mortality 8 1.49 1.13, 1.97 8 1.11 0.82, 1.52 8 1.40 1.04, 1.89 8 1.36 0.92, 2.03
*N=number of studies included in the meta-analysis
Controlled for socioeconomic and maternal nutritional variables from Supplemental Table 1 in Additional file 1.
Reference exposure: parity 1-2 / Age 18-<35.
SGA = small-for-gestational-age, defined as below the 10th percentile of the U.S. 1991 reference distribution described by Alexander and colleagues [38]. AGA =
appropriate-for-gestational-age. Preterm = below 37 completed weeks of gestation.
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young age; women who were both nulliparous and age
<18 consistently experienced the highest risk. Young age
appeared to drive preterm risk, as seen in the statisti-
cally significantly different preterm associations compar-
ing nulliparous women age <18 to age 18-<35. When
we conducted sensitivity analyses using a lower age cut-
off of 16, the associations increased in magnitude, parti-
cularly for preterm outcomes. Although the change in
associations were not statistically significant, this may be
driven by sample size, as we had a very low prevalence
of women under age 16. Several studies have reported
increased rates of preterm delivery and/or neonatal mor-
tality among young mothers [3,5,39,40]. A plausible bio-
logical explanation may be incomplete maternal physical
growth and relative malnutrition, which is related to the
mother’s gynecological age rather than chronological age
[3]. In a U.S. study, growing adolescents accrued more fat
and more weight during their pregnancy, but their infants
weighed less at birth and their mothers retained more
weight postpartum [41]. In resource-constrained settings,
adolescent mothers may have an even larger nutritional
burden; a study in rural Nepal observed lighter newborns
and a larger loss of mid-upper arm circumference in
pregnancy among adolescent mothers than their older
counterparts [42]. The association with young age may
also be related to women taking two years post-menarche
or longer to reach their adult stature and pelvic dimen-
sions [43]. We did not have data on gynecological age to
explore this issue.
For age ≥35, we witnessed an increase in risk of pre-
term birth, but no association with SGA. The preterm
association may be attributed to greater incidence of
chromosomal or congenital abnormalities, or confound-
ing by maternal morbidities such as gestational diabetes,
pre-eclampsia, and hypertension, as well as chronic dis-
ease, which may be more common among older
mothers [9,44]. Previous studies link advanced maternal
age to increased risk of preterm delivery and poor peri-
natal outcomes, with age having a dose response rela-
tionship to risk [9,45]. There were not enough women
in our data with advanced age to explore a possible
dose response relationship of age beyond 35.
Figure 1 Adjusted odds ratios for adverse outcomes, by Term-SGA, Preterm-AGA, and Preterm-SGA (reference: Term-AGA). SGA =
small-for-gestational-age, defined as below the 10th percentile of the U.S. 1991 reference distribution described by Alexander and colleagues
[38]. AGA = appropriate-for-gestational-age. Preterm = below 37 completed weeks of gestation.
Kozuki et al. BMC Public Health 2013, 13(Suppl 3):S2
http://www.biomedcentral.com/1471-2458/13/S3/S2
Page 6 of 10
Our analysis yielded mixed results on the association
between parity ≥3 and adverse outcomes. We saw no
adverse association with SGA, and a weak association
with preterm. WWhen we conducted sensitivity analyses
by raising the parity cut-off to ≥5, we saw no dose
response relationship, which puts into question an
actual biological association between high parity and
adverse newborn outcomes. This hypothesis is sup-
ported by some previous literature. A separate analysis
in this supplement using DHS datasets [46] noted that
the increased mortality risk among high parity infants
was attributable mostly, if not entirely, to confounders
strongly correlated with the mother having high fertility
at the end of her reproductive period. A series of studies
from Israel also attributed higher rates of negative out-
comes to socioeconomic and environmental factors
highly correlated with high parity [10,47,48]. Finally, sev-
eral studies have reported that grand multiparous
women had no increased risk in contexts where women
were economically stable or had proper access to care
[49-51]. In light of these findings, we believe that residual
confounding, and not biological mechanisms, may fully
account for the association between high parity and
adverse outcomes. It is unclear why we see a slight, but
significant protective association between parity ≥3 and
SGA. With the parity ≥5 cut-off, the magnitude of the
associations remained almost identical, although the
associations lost statistical significance. The lack of
change in risk with increasing parity may again hint that
confounders not captured by the covariates in our data
are at play.
All risk categories had a statistically significant associa-
tion with neonatal mortality, with age <18 and age ≥35
appearing to be the largest drivers of mortality. Only nul-
liparous/age <18 and parity≥3/age 18-<35 retained statis-
tically significant associations with infant mortality. The
parity and age risks may be operating on mortality
through SGA/preterm and/or confounders like socioeco-
nomic characteristics or access to care that may not have
been fully captured by the available control variables.
An increase in contraceptive prevalence has been effec-
tive in reducing high parity and advanced age births, but
not in delaying maternal age at first birth. Stover and
Ross report an extremely low correlation of R2=0.05
between contraceptive prevalence rate and percentage of
births with mothers age <18 years [52]. This implies the
need to focus on addressing adolescent pregnancies and
for innovative strategies that may be more successful in
delaying age at first birth. This may mean expanding the
scope of interventions beyond the health sector; for
instance, some literature suggests that educational attain-
ment delays age to first birth [53-55]. In finding effective
interventions, it is also important to understand factors
beyond knowledge and access that motivate reproductive
decisions. For instance, survival of previous children and
desired family size could be driving higher age and parity
births, and depending on the circumstances, ensuring
child survival may be more effective in addressing repro-
ductive risk than family planning. Finally, there is a need
to address the equity issues surrounding access to family
planning. There are substantial gaps in contraceptive pre-
valence between women belonging to high wealth quin-
tiles and to low wealth quintiles [56,57]. Those who have
the least access are most likely the ones who need it the
most, as suggested by our concerns with residual
confounding.
The strength of our analyses is the use of high quality,
population-based cohort data that allows us to make
better inferences of causation. We have examined how
parity and maternal age together may impact outcome,
rather than simply using one or the other as a control
variable. We were also able to use standardized defini-
tions for both exposures and outcomes, enhancing com-
parability across studies. Previous studies have used a
variety of cut-offs and definitions for parity and age
[3,4,15,16]. Taking SGA as an example, even using the
most widely accepted definition (under 10th percentile
of a reference distribution), the prevalence of SGA can
vary depending on which reference distribution is being
used. SGA prevalence ranged from 5-72% when applying
existing reference distributions to a single population
sample (Joanne Katz, personal communication).
A weakness of our study is the limit of confounders
available in each primary study. We controlled for the
available confounders, but there still remains the possibility
of residual confounding. In addition to our aforementioned
discussion on high parity and residual confounding, there
is also literature suggesting that controlling for socioeco-
nomic characteristics largely attenuates the risk of adverse
outcomes with young maternal age [58,59]. Although there
is strong evidence for biological mechanisms linking nulli-
parity to adverse outcomes, those associations may also
still be partially confounded by factors like quality and/or
access to health care. Birth interval is another reproductive
factor that could be a confounder, but was not included in
this analysis, as a majority of the studies did not have that
information. A separate study in this supplement evaluates
the associations between birth intervals and poor out-
comes, controlling for parity and maternal age in a subset
of our datasets with relevant information [60]. Variables
like survival of previous children may reflect underlying
maternal health and socioeconomic conditions that are not
well captured in the available variables.
Due to limitations of the data, we were not able to
explore gravidity (all pregnancies), instead of parity (all
live births), as the exposure. Using gravidity instead may
have given us additional insight into the mechanisms link-
ing parity and birth outcome; particularly with stillbirths
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and less so with miscarriages, we would expect mothers to
endure similar nutritional demand during pregnancy as a
live birth. Furthermore, by not taking into account miscar-
riages and stillbirths as outcomes, we may be underesti-
mating the negative impact of some of the risk factors.
There is existing literature that links nulliparity with still-
birth and intrapartum-related neonatal mortality [6,61,62].
A systematic review showed increased risk of stillbirth and
perinatal death with older maternal age [63]. In contrast,
publications have produced mixed findings pertaining to
the associations between high parity and stillbirth [6,64] as
well as young maternal age and stillbirth [3]. Collecting
more detailed information may help us better understand
the mechanisms linking reproductive health risk factors to
adverse fetal and perinatal outcomes, and support better-
designed and better-timed interventions for at-risk
mothers and newborns.
Although the studies included in our analyses are all
population-based studies, we acknowledge that the data
are not nationally representative. However, we believe that
the risk associations we present here are less likely to be
influenced by this, as prevalence estimates may be. Finally,
we were only able to conduct sensitivity analyses of the
parity ≥5 and age <16 years cut-offs on the datasets avail-
able to the primary author and with high enough preva-
lence in the respective categories.
Conclusions
The highest odds of adverse neonatal outcomes asso-
ciated with nulliparous/age <18 mothers and also the
increased odds seen among parity ≥3/age ≥35 mothers
indicate that reproductive health interventions and edu-
cation need to occur throughout a woman’s reproductive
period. Delaying maternal age at first birth could
decrease risk for all adverse neonatal outcomes, but
family planning interventions appear to be the least suc-
cessful in addressing this risk factor. This calls upon
family planning experts to refocus their efforts on finding
interventions that will more effectively address this issue.
For LiST, we recommend including no association
between high parity and adverse newborn outcomes.
We recommend including the associations presented
here for nulliparity, age <18 years, and age ≥35 years,
with the caveat that the associations may still be influ-
enced by residual confounding.
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